D. E. Shaw & Co., Inc. Kura Oncology, Inc. Transaction History

D. E. Shaw & Co., Inc.

$114 Billion
Q1 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Kura Oncology, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 389,902 shares of KURA stock, worth $8.02 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

389,902

Previous 205,620 89.62%

Holding current value

$8.02 Million

Previous $2.96 Million 181.33%

% of portfolio

0.01%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.42 - $23.53 $2.47 Million - $4.34 Million	184,282 Added 89.62%	389,902 $8.32 Million
Q4 2023 Feb 14, 2024	SELL	$7.58 - $14.38 $11,218 - $21,282	-1,480 Reduced 0.71%	205,620 $2.96 Million
Q3 2023 Nov 14, 2023	SELL	$8.44 - $11.86 $42,562 - $59,809	-5,043 Reduced 2.38%	207,100 $1.89 Million
Q2 2023 Aug 14, 2023	BUY	$9.62 - $13.99 $404,646 - $588,461	42,063 Added 24.73%	212,143 $2.24 Million
Q1 2023 May 15, 2023	SELL	$10.71 - $14.6 $83,056 - $113,223	-7,755 Reduced 4.36%	170,080 $2.08 Million

Q4 2022 Feb 14, 2023	SELL	$11.23 - $16.9 $1.14 Million - $1.72 Million	-101,624 Reduced 36.36%	177,835 $2.21 Million
Q3 2022 Nov 14, 2022	BUY	$12.01 - $19.45 $2.26 Million - $3.67 Million	188,559 Added 207.44%	279,459 $3.82 Million
Q2 2022 Aug 15, 2022	BUY	$10.71 - $18.33 $289,191 - $494,946	27,002 Added 42.26%	90,900 $1.67 Million
Q1 2022 May 16, 2022	SELL	$11.78 - $16.98 $1.12 Million - $1.61 Million	-95,036 Reduced 59.8%	63,898 $1.03 Million
Q4 2021 Feb 14, 2022	BUY	$12.22 - $19.57 $292,412 - $468,290	23,929 Added 17.72%	158,934 $2.23 Million
Q3 2021 Nov 15, 2021	SELL	$15.42 - $21.72 $2.53 Million - $3.56 Million	-164,005 Reduced 54.85%	135,005 $2.53 Million
Q2 2021 Aug 16, 2021	SELL	$20.85 - $29.88 $1 Million - $1.44 Million	-48,180 Reduced 13.88%	299,010 $6.23 Million
Q1 2021 May 17, 2021	SELL	$24.75 - $39.14 $5.78 Million - $9.14 Million	-233,403 Reduced 40.2%	347,190 $9.82 Million
Q4 2020 Feb 16, 2021	BUY	$29.0 - $41.62 $6.99 Million - $10 Million	240,962 Added 70.95%	580,593 $19 Million
Q3 2020 Nov 16, 2020	BUY	$16.3 - $30.64 $1.24 Million - $2.33 Million	76,174 Added 28.91%	339,631 $10.4 Million
Q2 2020 Aug 14, 2020	BUY	$7.95 - $18.81 $712,455 - $1.69 Million	89,617 Added 51.55%	263,457 $4.29 Million
Q1 2020 May 15, 2020	SELL	$6.45 - $14.04 $576,501 - $1.25 Million	-89,380 Reduced 33.96%	173,840 $1.73 Million
Q4 2019 Feb 14, 2020	BUY	$12.97 - $15.94 $873,166 - $1.07 Million	67,322 Added 34.37%	263,220 $3.62 Million
Q3 2019 Nov 14, 2019	BUY	$14.75 - $20.87 $1.68 Million - $2.38 Million	113,894 Added 138.89%	195,898 $2.97 Million
Q2 2019 Aug 14, 2019	BUY	$14.71 - $19.79 $1.21 Million - $1.62 Million	82,004 New	82,004 $1.62 Million

Others Institutions Holding KURA

# of Institutions

174

Shares Held

80.4M

Call Options Held

914K

Put Options Held

120K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $1.38B
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account